Platelet Reactivity and Coagulation Markers in Patients with COVID-19

ConclusionPatients hospitalized with non-severe COVID-19 had lower PR compared to healthy controls, despite having higher levels ofd-dimer, fibrinogen, and PAI-1, and hypercoagulability by thromboelastometry.Trial RegistrationClinicalTrials.gov identifier, NCT04447131.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research